Exhaled breath analysis for identifying eosinophilic and neutrophilic inflammation in a mixed population of patients with asthma or COPD Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016
Relation of exhaled breath temperature and systemic markers of inflammation and remodelling in stable bronchial asthma Source: International Congress 2016 – Airway biomarkers Year: 2016
Exhaled NO but not eosinophilic inflammation is reduced by inhaled corticosteroid treatment in COPD Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013
Changes in PH of exhaled breath condensate after specific inhalation challenge test, in patients with hypersensitivity pneumonitis Source: International Congress 2014 – ILDs 3 Year: 2014
Tracking pulmonary exacerbations in preschool children using the lung clearance index Source: International Congress 2016 – Cystic fibrosis: monitoring and management Year: 2016
Early detection of pulmonary exacerbations in children with cystic fibrosis by electronic home monitoring of symptoms and lung function Source: International Congress 2016 – Cystic fibrosis: monitoring and management Year: 2016
Can Scond and Sacin be estimated from two multiple breath washout tests across childhood? Source: International Congress 2015 – Paediatric respiratory physiology Year: 2015
Exercise testing and multiple breath washout as markers of lung disease among patients with cystic fibrosis Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous Year: 2015
Unbiased clustering of severe asthma patients based on exhaled breath profiles Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015
Exhaled breath condensate hydrogen peroxide in obstructive airways disease Source: International Congress 2014 – Airway biomarkers Year: 2014
Clinically relevant early functional and diagnostic markers of lung disease in children Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=120 Year: 2006
Conductivity in exhaled breath condensate of patients with asthma, COPD or cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 227s Year: 2005
Cytokines in exhaled breath condensate of children with asthma and cystic fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 468s Year: 2004
Lung clearance index during pulmonary exacerbation in school-age children with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013
Analysis of exhaled air for a rapid, sensible and specific diagnosis of COPD Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015
Exhaled pentane – a new breath test in cystic fibrosis? Source: Annual Congress 2006 - New developments in infant and intensive care lung function Year: 2006
Inflammatory markers in exhaled breath condensate, assessed by means of Luminex® technology, can differentiate between children with asthma, cystic fibrosis and healthy controls Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome Year: 2007
Exhaled particles from small airways in COPD patients – A pilot study Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014
Volatile organic compounds in exhaled breath of patients with COPD ± lung cancer and their correlation with FEV1-values Source: International Congress 2014 – The assessment of comorbidities Year: 2014
Lung clearance index predicts pulmonary exacerbations in cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014